VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Vaccine Mechanisms
Vaximmutordb
Vaxism
Vaxar
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UMMS Logo

Vaccine Comparison

Murine cytomegalovirus DNA vaccine pcDNA-89 encoding pp89 Murine cytomegalovirus DNA vaccine pgM-pgN
Vaccine Information Vaccine Information
  • Vaccine Ontology ID: VO_0004323
  • Type: DNA vaccine
  • Status: Research
  • Host Species as Laboratory Animal Model: Mouse
  • IE1 gene engineering:
    • Type: DNA vaccine construction
    • Description: Vector pcDNAI/Amp expressed the murine cytomegalovirus (MCMV) immediate-early gene 1 (IE1) encodes an 89-kDa phosphoprotein (pp89) (González et al., 1996).
    • Detailed Gene Information: Click Here.
  • Vector: pcDNAI/Amp (González et al., 1996)
  • Immunization Route: Intradermal injection (i.d.)
  • Vaccine Ontology ID: VO_0004526
  • Type: DNA vaccine
  • Status: Research
  • Host Species as Laboratory Animal Model: Mouse
  • Antigen: gM and gN from murine cytomegalovirus strain Smith (Wang et al., 2013)
  • gM gene engineering:
    • Type: DNA vaccine construction
    • Detailed Gene Information: Click Here.
  • gN gene engineering:
    • Type: DNA vaccine construction
    • Detailed Gene Information: Click Here.
  • Vector: pcDNA3.1 (Wang et al., 2013)
  • Immunization Route: Intramuscular injection (i.m.)
Host Response Host Response

Mouse Response

  • Vaccine Immune Response Type: VO_0000286
  • Efficacy: In four separate trials, an average of 63% of the mice immunized with pcDNA-89 survived after lethal challenge, compared with 18% of the mice immunized with pcDNA (control) (González et al., 1996).

Mouse Response

  • Vaccine Immune Response Type: VO_0000286
  • Efficacy: Co-immunization with pgM and pgN three times at a high dose was able to provide mice with full protection against a lethal SG-MCMV challenge with a 100% survival rate. The protection obtained with the gM-gN co-immunization was far greater than each antigen alone (Wang et al., 2013).
References References
González et al., 1996: González Armas JC, Morello CS, Cranmer LD, Spector DH. DNA immunization confers protection against murine cytomegalovirus infection. Journal of virology. 1996; 70(11); 7921-7928. [PubMed: 8892915].
Wang et al., 2013: Wang H, Yao Y, Huang C, Chen Q, Chen J, Chen Z. Immunization with cytomegalovirus envelope glycoprotein M and glycoprotein N DNA vaccines can provide mice with complete protection against a lethal murine cytomegalovirus challenge. Virologica Sinica. 2013; ; . [PubMed: 23715998].